{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-003387","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2026-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.987044+00:00","generated_at":"2026-05-16T04:06:39.005199+00:00","sec_items":["1.01","3.02","3.03","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Catheter Precision raises $2.18M in private placement, acquires 19.98% stake in FLYTE for $5.25M","bullets":["Initial closing of private placement yields $2.18M; additional closings could raise up to ~$44.6M total.","Issues Series C-1 convertible preferred at $1.43/share; conversion price can reset to 80% of market price after stockholder approval.","Acquires 19.98% of Fly Flyte, Inc. (air-mobility) for $5.25M in Series D convertible preferred, contingent on stockholder approval.","Existing Series B preferred and warrants repriced to $1.78, generating $400k cash from warrant exercises.","Proceeds to repay debt, wind down legacy catheter business, and explore going-private or spin-off transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-003387","json":"https://secwatch.observer/filing/0001437749-26-003387.json","markdown":"https://secwatch.observer/filing/0001437749-26-003387.md","text":"https://secwatch.observer/filing/0001437749-26-003387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/vtak20260206_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:06:39.005199+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"144d99fe8e54d2fd0a9429769ae047ecc9ae2562","claim":"Catheter Precision, Inc. issued 392,608 shares of common stock to certain accredited investors for $1.43 per share.","evidence_excerpt":"Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"392,608 shares"},{"label":"Purchaser","value":"certain accredited investors"},{"label":"Consideration","value":"$1.43 per share"}],"fact_type":"equity_issuance"},{"claim_id":"b05897def2af4ebadf551d6e6ca28e3da22f347e","claim":"Catheter Precision, Inc. issued 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock of preferred stock to certain accredited investors for stated value of $1,000 per share.","evidence_excerpt":"of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock"},{"label":"Purchaser","value":"certain accredited investors"},{"label":"Consideration","value":"stated value of $1,000 per share"}],"fact_type":"equity_issuance"},{"claim_id":"0b90f1fa50d023187184474237c92142ffdedd22","claim":"Catheter Precision, Inc.: Filing of Certificate of Designations for Series C-1 Preferred Stock, referenced as a charter amendment under Item 5.03.","evidence_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm","confidence":0.4,"family_label":"Governance Changes","details":[{"label":"Change","value":"fiscal year change"}],"fact_type":"governance_change"},{"claim_id":"ea147f2315cb3dc16921b9e4047c0ba1fa7638f5","claim":"Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at $2,177,759.00 (effective 2026-02-06).","evidence_excerpt":"On February 6, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with the Common Shares, the “Initial Securities”), for an aggregate purchase price of $2,177,759.00 with respect to the Initial Securities","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$2,177,759.00"},{"label":"Effective","value":"2026-02-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}